Navigation Links
New research: Soy germ isoflavones reduce bone loss

A new study published in this month's European Journal of Nutrition demonstrates a strong correlation between reducing bone loss in non-obese postmenopausal women and the dose-dependent effect of soy germ isoflavones, particularly SoyLife®. These findings support previous scientific findings regarding soy isoflavones for post-menopausal women.

According to the authors of the study, "Osteoporosis is a health condition experienced by about one in three postmenopausal women, with estrogen deficiency often acting as the major cause. Hormone replacement therapy has been the most effective treatment for maintaining bone density. This treatment often has adverse side effects such as an increased risk for endometrial cancer and breast cancer."

"It is imperative to find natural, safe and effective alternatives for women to help maintain bone health after menopause ?without the risky side effects associated with long-term hormone replacement therapy use. This promising research is another step in advancing soy germ isoflavones as a safe, effective option," said Jocelyn Mathern, RD and Technical Specialist, Acatris.

The study aimed to examine the effects of a high-dose supplementation of soy germ isoflavones (84 and 126 mg SoyLife® EXTRA/day) in slowing bone loss in 90 early postmenopausal Chinese women. Isoflavones are found predominately in soy products. Their structure and functions are similar to estrogen, and observational studies suggest that higher intakes of soy and soy products may lower the prevalence of osteoporosis.

Soy isoflavones have been supported by proprietary scientific studies to promote women's health, bone health, heart health, prostate health and cognitive function. A focus of the study, SoyLife® is a range of ingredients from soy germ, rich in isoflavones. More than just an isoflavone concentrate, SoyLife® offers the complete spectrum of natural soy compounds, the Soy MatrixTM, which enhances the bio-ava ilability of isoflavones.

"In addition to this research, more studies are examining the effects of either soy or isoflavones on bone density in humans," said Mathern. "We are awaiting results of a large study, the Osteoporosis Prevention Using Soy (OPUS) study, a multi-site, two year research study on the use of soy isoflavones to prevent bone loss in 400 postmenopausal women. Both this current study and OPUS used SoyLife®, and we're excited to see SoyLife® helping lead the way in determining the required dosage of soy isoflavones for safely decreasing bone loss and preventing osteoporosis in postmenopausal women."

Another recent study published in the journal of Fertility and Sterility demonstrated soy isoflavones' effectiveness and key role in improving mood and cognitive function in postmenopausal women. This research strongly points to soy isoflavone supplementation as a natural, effective way to significantly improve the quality of life for postmenopausal women.


'"/>

Source:MWW Group


Related biology news :

1. Male circumcision reduces risk of HIV transmission from women to men
2. Deficiency of growth hormone and IGF-1 reduces cancer and kidney disease, but creates other problems
3. Use of PET can reduce, may eliminate more strenuous drug development trials with animals
4. Solutions that reduce death of marine life reeled in by International Smart Gear Competition
5. Physiological effects of reduced gravity on bacteria
6. New strategies to reduce hospital-aquired infections
7. New miniaturised chip dramatically reduces time taken for DNA analysis
8. Scalpel-free surgery could reduce risk of HIV and hepatitis exposure for health care workers
9. New processing method reduces peanut allergenicity
10. Newly recognized gene mutation may reduce seeds, resurrect plants
11. Blocking the nerve receptor EP1 in mouse models reduces brain damage caused by stroke
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/9/2016)... Mass., Feb. 9, 2016 Aware, Inc. (NASDAQ: AWRE ... financial results for its fourth quarter and year ended December 31, ... for the fourth quarter of 2015 was $6.9 million, an increase ... year. Operating income in the fourth quarter of 2015 was $2.6 ... --> --> Higher revenue ...
(Date:2/4/2016)... , Feb. 4, 2016 The ... apparently one of the most popular hubs of ... MetaHIT and other huge studies of human microbiota, ... past few years, the microbiome space has literally ... biomedical research. This report focuses on biomedical ...
(Date:2/3/2016)... , Feb. 3, 2016 ... addition of the "Emotion Detection and ... Learning, and Others), Software Tools (Facial Expression, ... End Users,and Regions - Global forecast to ... --> http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... CRUZ, Calif. , Feb. 11, 2016  Dovetail ... applications to its beta program for a planned metagenomic ... will present the company,s metagenomic genome assembly method in ... Advances in Genome Biology & Technology conference in ... assembly of these highly complex datasets is difficult. Using ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global Stem Cells ... in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art techniques ... the world. , The new GSCG clinic is headed by four prominent ...
(Date:2/10/2016)... is introducing a hybrid membership model which will provide ... joining or renewing through an organizational purchasing model. For ... employee in any size association or AMC office can ... benefits.   John H. Graham, IV , ... organizations of any size and their employees to gain ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, a fully-integrated network ... two long-standing principal investigators (PI) to the roles of Chief Medical Officer, Clinical ... Dr. Laurence Chu, a Benchmark Research PI in the Austin office, will assume ...
Breaking Biology Technology: